Sulfazecin and isosulfazecin, novel β-lactam antibiotics of bacterial origin

Abstract
The first evidence that novel monocyclic .beta.-lactam antibiotics, sulfazecin and isosulfazecin, are produced by a Pseudomonas sp., is reported. These antibiotics displayed antimicrobial activities against several species of pathogenic bacteria.